Erschienen in:
01.08.2009 | Letter
Laparoscopic gastrectomy for organ-confined cancer: a reality in the west?
verfasst von:
Ernst Hanisch, Dimosthenis Ziogas
Erschienen in:
Surgical Endoscopy
|
Ausgabe 8/2009
Einloggen, um Zugang zu erhalten
Excerpt
Open gastrectomy with extended (D2) lymphadenectomy for the treatment of resectable gastric cancer has become the de facto standard of care in Japan and Korea. Excellent outcomes for advanced stages of this disease have reported recently from a high-quality, multicenter, phase III, randomized, controlled trial at 24 hospitals in Japan [
1]. Sasako et al. reported a 5-year survival rate of 70% with extended lymphadenectomy for Japanese stages II and III disease without adjuvant treatment [
1]. Yet, these results represent a dream for the real western world [
2]. Even in specialized institutions in the west, 5-year survival rate for these advanced stages is reported to be less than 40%, and notably these data are derived from nonrandomized studies [
3‐
7]. …